Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

STS01 1% effectively promotes hair regrowth with minimal side effects.

New methods improve skin disease diagnosis and treatment.

N793 may improve hair density in people with mild hair thinning.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Growth Factor Concentrate is more effective than Platelet-Rich Plasma for improving hair density and thickness.

Oral minoxidil improved hair loss more than oral dutasteride.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Hair transplant works well, but needs more research for better results.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Men with early-onset baldness may have a higher risk of heart disease.

Baldness may indicate higher heart disease risk in men.

Early hair loss may indicate risk of insulin resistance.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Skin symptoms can indicate endocrine disorders and have various treatments.

Bald men are often viewed more negatively and as older than they really are.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.